Season and sunshine hours may affect live birth rates after IVF

Mer­ck and Mod­er­na will be­gin their Phase III can­cer vac­cine tri­al in Au­gust, ac­cord­ing to a fed­er­al clin­i­cal tri­als data­base. The close­ly watched tri­al could

The FDA approved lazertinib (Lazcluze) in combination with amivantamab (Rybrevant) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with

Roche’s Susvimo was first approved by the US Food and Drug Administration (FDA) to treat wet AMD in 2021. Image Credit: Michael Derrer Fuchs /